Cas No.187022-49-7 Phenyl 3,4,6-Tri-O-acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxyformamido)-β-D-glucopyranoside

Glycosylation modification can significantly affect the water solubility, stability, and metabolic pathways of drugs. This compound, as an intermediate in drug development, can be used to synthesize glycosylated drugs, especially those that improve drug efficacy or targeting through glycosylation. For example, glycosylated anticancer drugs, antiviral drugs, etc., optimize their pharmacokinetics and bioavailability by modifying the sugar structure. In addition, the trichloroethoxyformamide group and phenyl glycoside moiety in the compound may endow it with antibacterial or anticancer activity. By further modification, the development of biologically active drug molecules may play a role in antibacterial, antiviral, or anticancer treatments.